Challenges of Treating a Patient With Advanced Prostate Cancer During the COVID-19 Pandemic.
Oncology (Williston Park)
; 34(8): 317-319, 2020 08 12.
Artículo
en Inglés
| MEDLINE | ID: covidwho-713075
ABSTRACT
A 78-year-old man had a medical history of hypertension, atrial fibrillation, chronic kidney disease, and metastatic castration-resistant prostate cancer (CRPC). He had progressed to first-line therapy for CRPC with abiraterone plus androgen-deprivation therapy (ADT) and as second-line therapy he was being treated with docetaxel, with biochemical progression in his last prostate specific antigen measurement. He was admitted to the hospital on April 2020, in the middle of the coronavirus disease 2019 (COVID-19) pandemic, because of painful bone lesions and deterioration of renal function.
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Cuidados Paliativos
/
Neumonía Viral
/
Insuficiencia Respiratoria
/
Neoplasias Óseas
/
Infecciones por Coronavirus
/
Neoplasias de la Próstata Resistentes a la Castración
/
Anticoagulantes
Tipo de estudio:
Reporte de caso
/
Estudio pronóstico
Tópicos:
Covid persistente
Idioma:
Inglés
Revista:
Oncology (Williston Park)
Asunto de la revista:
Neoplasmas
Año:
2020
Tipo del documento:
Artículo
País de afiliación:
ONC.2020.3408.0317
Similares
MEDLINE
...
LILACS
LIS